JP2013537887A5 - - Google Patents

Download PDF

Info

Publication number
JP2013537887A5
JP2013537887A5 JP2013527651A JP2013527651A JP2013537887A5 JP 2013537887 A5 JP2013537887 A5 JP 2013537887A5 JP 2013527651 A JP2013527651 A JP 2013527651A JP 2013527651 A JP2013527651 A JP 2013527651A JP 2013537887 A5 JP2013537887 A5 JP 2013537887A5
Authority
JP
Japan
Prior art keywords
trpm8
ethyl
methyl
isopropyl
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013527651A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013537887A (ja
Filing date
Publication date
Priority claimed from ES201031341A external-priority patent/ES2377785B2/es
Application filed filed Critical
Publication of JP2013537887A publication Critical patent/JP2013537887A/ja
Publication of JP2013537887A5 publication Critical patent/JP2013537887A5/ja
Withdrawn legal-status Critical Current

Links

JP2013527651A 2010-09-08 2011-09-08 ドライアイの治療用医薬組成物 Withdrawn JP2013537887A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201031341A ES2377785B2 (es) 2010-09-08 2010-09-08 Composición farmacéutica para el tratamiento del ojo seco.
ESP201031341 2010-09-08
PCT/ES2011/070627 WO2012032209A2 (es) 2010-09-08 2011-09-08 Composición farmacéutica para el tratamiento del ojo seco

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016190040A Division JP2017036298A (ja) 2010-09-08 2016-09-28 ドライアイの治療用医薬組成物

Publications (2)

Publication Number Publication Date
JP2013537887A JP2013537887A (ja) 2013-10-07
JP2013537887A5 true JP2013537887A5 (enExample) 2015-08-13

Family

ID=45811010

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2013527651A Withdrawn JP2013537887A (ja) 2010-09-08 2011-09-08 ドライアイの治療用医薬組成物
JP2016190040A Withdrawn JP2017036298A (ja) 2010-09-08 2016-09-28 ドライアイの治療用医薬組成物
JP2019094210A Pending JP2019131621A (ja) 2010-09-08 2019-05-20 ドライアイの治療用医薬組成物
JP2021068077A Ceased JP2021107422A (ja) 2010-09-08 2021-04-14 ドライアイの治療用医薬組成物
JP2024039617A Pending JP2024069452A (ja) 2010-09-08 2024-03-14 ドライアイの治療用医薬組成物
JP2025143562A Pending JP2025172101A (ja) 2010-09-08 2025-08-29 ドライアイの治療用医薬組成物

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2016190040A Withdrawn JP2017036298A (ja) 2010-09-08 2016-09-28 ドライアイの治療用医薬組成物
JP2019094210A Pending JP2019131621A (ja) 2010-09-08 2019-05-20 ドライアイの治療用医薬組成物
JP2021068077A Ceased JP2021107422A (ja) 2010-09-08 2021-04-14 ドライアイの治療用医薬組成物
JP2024039617A Pending JP2024069452A (ja) 2010-09-08 2024-03-14 ドライアイの治療用医薬組成物
JP2025143562A Pending JP2025172101A (ja) 2010-09-08 2025-08-29 ドライアイの治療用医薬組成物

Country Status (5)

Country Link
US (4) US9095609B2 (enExample)
EP (2) EP4268814A3 (enExample)
JP (6) JP2013537887A (enExample)
ES (1) ES2377785B2 (enExample)
WO (1) WO2012032209A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2377785B2 (es) * 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
JP6110124B2 (ja) * 2012-04-18 2017-04-05 花王株式会社 運動神経活性化用皮膚塗布剤
CN103040976B (zh) * 2012-12-31 2014-01-15 刘建贞 一种促进面神经损伤外科吻合术后康复的药物
EP3060569B8 (en) * 2013-10-22 2021-11-24 IVIEW Therapeutics, Inc. Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort
JP6692162B2 (ja) * 2014-01-17 2020-05-13 キッセイ薬品工業株式会社 α−置換グリシンアミド誘導体
US20150290029A1 (en) * 2014-04-11 2015-10-15 Edward Tak Wei Delivery Systems for Agents to treat Ocular Discomfort
MX2017005046A (es) * 2014-10-31 2017-07-04 Avent Inc Metodo y articulos para inhibir las contracciones vesicales.
WO2017062570A1 (en) * 2015-10-06 2017-04-13 Ora, Inc. Transient receptor potential cation channel subfamily m member 8 (trpm8) antagonists and methods of use
EP3184524A1 (en) 2015-12-21 2017-06-28 Dompé farmaceutici S.p.A. 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists
ES2625393A1 (es) * 2016-01-19 2017-07-19 Universidad Miguel Hernandez De Elche Compuestos agonistas del receptor trpm8 y sus aplicaciones
JP2020531473A (ja) * 2017-08-18 2020-11-05 ザ スケペンス アイ リサーチ インスティテュート，インコーポレイテッド ドライアイの処置のための組成物およびその使用の方法
EP3781175A1 (en) 2018-04-18 2021-02-24 i.com Medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
GB201807305D0 (en) * 2018-05-03 2018-06-20 Nicoventures Trading Ltd Vaporisable formulation
JP6564498B2 (ja) * 2018-06-06 2019-08-21 エドワード タク ウェイＷＥＩ， Ｅｄｗａｒｄ Ｔａｋ 感覚的不快感の治療向け局所薬としてのジ−イソプロピル−アルカン（ｄａｐａ）化合物
WO2020157570A1 (en) 2019-01-31 2020-08-06 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
WO2020160464A1 (en) * 2019-02-01 2020-08-06 Marshall University Research Corporation Transient receptor potential melastatin 8 (trpm8) antagonists and related methods
WO2021195256A1 (en) * 2020-03-24 2021-09-30 Aerie Pharmaceuticals, Inc. Pharmaceutical preparation
US20220087997A1 (en) * 2020-09-22 2022-03-24 Fertin Pharma A/S Oral Antagonist Compositions For Nicotine Burning Relief
WO2022105986A1 (de) * 2020-11-17 2022-05-27 Symrise Ag Neue kühlstoffe und zubereitungen, die diese enthalten
US12397518B2 (en) * 2021-04-29 2025-08-26 Coopervision International Limited WS12-releasing contact lens
WO2022257981A1 (zh) * 2021-06-08 2022-12-15 广州岐微生物医药科技有限公司 化合物在抑制或杀灭螨虫及治疗干眼症中的应用
IL313616A (en) * 2021-12-17 2024-08-01 Aerie Pharmaceuticals Inc Ophthalmic pharmaceutical compositions and uses thereof
US20230350228A1 (en) 2022-04-28 2023-11-02 Coopervision International Limited Contact lens
GB2629125B (en) 2022-10-31 2025-06-25 Coopervision Int Ltd WS12-releasing contact lens
WO2024220876A1 (en) * 2023-04-19 2024-10-24 Alcon Inc. N-substituted c6 cyclyl carboxamide compounds and uses thereof
TW202534349A (zh) 2023-10-27 2025-09-01 英商庫博光學國際有限公司 隱形眼鏡

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179121A (en) 1981-04-27 1982-11-04 Showa Kagaku Kogyo Kk Remedy for oculopathy
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US5176996A (en) 1988-12-20 1993-01-05 Baylor College Of Medicine Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
US5256775A (en) 1989-06-05 1993-10-26 Gilead Sciences, Inc. Exonuclease-resistant oligonucleotides
US5264564A (en) 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
JPH1067684A (ja) * 1996-06-17 1998-03-10 Mitsubishi Chem Corp 涙液分泌促進剤
HUP9904697A3 (en) 1996-10-11 2001-06-28 Bristol Myers Squibb Company P Methods and compositions for immunomodulation
CN1199617A (zh) 1996-12-18 1998-11-25 虎发光 一种治疗眼病的中成药
JPH10236972A (ja) * 1997-02-28 1998-09-08 Mitsubishi Chem Corp 涙液分泌促進剤
JP4591728B2 (ja) * 1998-12-28 2010-12-01 大正製薬株式会社 眼精疲労改善用点眼剤
JP3142842B1 (ja) * 1999-10-22 2001-03-07 ライオン株式会社 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
AU1731101A (en) * 1999-12-07 2001-06-18 Rohto Pharmaceutical Co., Ltd. Ophthalmic compositions
US7651686B2 (en) 2001-10-09 2010-01-26 Mayo Foundation For Medical Education And Research Enhancement of immune responses by 4-1bb-binding agents
WO2003064602A2 (en) * 2002-01-25 2003-08-07 The Regents Of The University Of California Methods of modulating cold sensory perception
US6919348B2 (en) * 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
BR0311337A (pt) 2002-05-28 2005-03-15 Altana Pharma Ag Uso oftalmológico de roflumilast para o tratamento de doenças do olho
JP2005536511A (ja) 2002-07-15 2005-12-02 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ ４−１ｂｂ結合物質を用いる治療及び予防
EP1539237A4 (en) 2002-07-30 2006-05-24 Bristol Myers Squibb Co HUMANIZED ANTIBODIES AGAINST HUMAN 4-1BB
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
DE10259619A1 (de) * 2002-12-18 2004-07-08 Metagen Pharmaceuticals Gmbh Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung
JP4601265B2 (ja) * 2003-05-14 2010-12-22 ロート製薬株式会社 局所適用製剤
CA2530884C (en) * 2003-07-02 2016-01-12 Genentech, Inc. Trp-p8 active compounds and therapeutic treatment methods
CN1565501A (zh) 2003-07-08 2005-01-19 毛友昌 明目地黄新的制备工艺及其制剂
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
WO2006040136A1 (en) 2004-10-13 2006-04-20 Bayer Healthcare Ag Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
WO2006062731A1 (en) * 2004-11-19 2006-06-15 University Of North Texas Health Science Center At Fort Worth Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
JP5078254B2 (ja) * 2004-12-17 2012-11-21 ロート製薬株式会社 眼科用組成物
EP2399935A3 (en) 2005-02-15 2012-02-22 GTC Biotherapeutics, Inc. An anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof
GB0504194D0 (en) * 2005-03-02 2005-04-06 Givaudan Sa Organic compounds
WO2007017092A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 4-benzyloxy-benzoic acid amide derivatives
CN1775261A (zh) 2005-11-18 2006-05-24 北京阜康仁生物制药科技有限公司 明目地黄制剂及新的制备方法
CN1775263A (zh) 2005-11-18 2006-05-24 北京阜康仁生物制药科技有限公司 杞菊地黄制剂及新的制备方法
US7727516B2 (en) * 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
RU2305517C1 (ru) 2006-03-09 2007-09-10 Сергей Васильевич Широков Способ лечения эпифоры
WO2007108541A1 (ja) * 2006-03-23 2007-09-27 Senju Pharmaceutical Co., Ltd. キサンタンガムおよびブドウ糖を含有する眼科用組成物
WO2008066644A1 (en) 2006-11-02 2008-06-05 Riolan Technologies, Inc. Methods of treating epiphora
GB2451503B (en) * 2007-08-01 2011-10-12 Lrc Products Stimulating gel comprising a cyclic carboxamide coolant
CN101612199A (zh) 2008-06-28 2009-12-30 孙斌 治疗眼睛红肿和遇风流泪的冲洗液
FR2934778B1 (fr) * 2008-08-11 2012-09-28 Natura Cosmeticos Sa Compositions d'anti-transpirants et procedes permettant de reduire la transpiration chez les humains
US8653099B2 (en) * 2008-08-19 2014-02-18 Janssen Pharmaceutica Cold menthol receptor antagonists
ES2377785B2 (es) * 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.

Similar Documents

Publication Publication Date Title
JP2013537887A5 (enExample)
RU2458920C2 (ru) Новые соединения
KR101455548B1 (ko) 비정형 항정신병약 및 taar1 작용제를 포함하는 조합물
JP2008531714A (ja) 不安障害の治療用及び／又は予防用の医薬組成物
JP2005539068A5 (enExample)
JP2012507538A5 (enExample)
JP6406713B2 (ja) 低用量薬剤によるうつ病および他の疾患の処置
JP2007519754A5 (enExample)
JP2006513261A5 (enExample)
JP2011524850A5 (enExample)
JP2010530431A5 (enExample)
NZ599577A (en) Substituted benzamide derivatives
JP2008110984A5 (enExample)
JP4800936B2 (ja) ヒスタミンレセプターｈ３のアンタゴニスト又は逆アゴニスト及び抗生精神病又は抗うつ病剤を含んで成る組み合わせ産物、並びにそれらの抗精神薬の不都合な効果を予防する医薬を調製するための使用
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
JP2008536946A (ja) うつ病の処置または予防のための新規の治療的組み合わせ
JP2017526724A5 (enExample)
TWI486336B (zh) 疼痛治療劑
JP2014523888A5 (enExample)
JP2012528824A5 (enExample)
JP2006512321A5 (enExample)
JP2006513222A5 (enExample)
TW200800148A (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
HRP20120344T1 (hr) N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije
RU2016146560A (ru) Производные морфолин-пиридина